The decision to use weight loss injections should be made collaboratively between patients, families, and healthcare providers, taking into account individual health status, previous weight management attempts, and potential risks and benefits
While injectable tirzepatide remains the standard, oral formulations are emerging, and they come with their own dosing considerations that differ markedly from the injection-based system we have been discussing
This finding was sustained at 12 months of follow-up, according to the study, which analyzed more than 18,000 patients with obesity, both with and without Type 2 diabetes
Some patients report that certain foods may feel particularly difficult to consume, though individual tolerance varies